Camelina sativa oil and fatty fish have major beneficial effect on lipid metabolism

Camelina sativa oil and fatty fish are rich in polyunsaturated omega-3 fatty acids, but their health benefits seem to differ. A new study from the University of Eastern Finland shows that Camelina sativa oil reduces the formation of fatty acid derivatives that may be harmful to cardiovascular health. Camelina sativa oil also seems to protect against oxidative stress. Fatty fish, on the other hand, increases the circulatory concentration of fatty acid derivatives that alleviate inflammation.

The study, conducted in collaboration between the University of Eastern Finland and Karolinska Institutet in Sweden, examined the associations of fatty and low-fat fish, and Camelina sativa oil, with lipid metabolism and low-grade inflammation. The study lasted for 12 weeks and it involved 79 men and women between 43 and 72 years of age and with impaired fasting glucose. The study participants were divided into four groups. One group replaced fats in their daily diet with Camelina sativa oil and reduced their intake of fish to one serving a week. Two of the groups ate fish four times a week: two servings of fatty fish, such as salmon or vendace, and two servings of low-fat fish, such as saithe or pike. The fourth group was a control group.

A high intake of omega-3 fatty acids from Camelina sativa oil and fatty fish reduced the circulatory proportions of arachidonic acid, which is a long-chain omega-6 fatty acid. Those using Camelina sativa oil also had lower concentrations of mediators derived from arachidonic acid, which may be harmful to cardiovascular health. Moreover, the intake of fatty fish increased the circulatory concentration of fatty acid derivatives that alleviate inflammation.

Camelina sativa oil and fatty fish had a major effect on lipid metabolism. Our study shows that dietary fats can be used to target metabolic pathways that are linked to cardiovascular diseases and type 2 diabetes."

Topi Meuronen, Early Stage Researcher, Lead Author of the Article, University of Eastern Finland

In addition to its other beneficial effects, Camelina sativa oil was also observed to reduce the circulatory concentration of markers that are indicative of oxidative stress. Low-fat fish, however, did not have an effect on the metabolic pathways studied.

In addition to measuring traditional fatty acid concentrations from blood, the researchers were also interested in changes that occur in fatty acid metabolites, which serve as mediators. An examination of fatty acid metabolism on this level makes it possible to study the effects of dietary polyunsaturated fatty acid in more detail than before. These new results are promising and they support earlier findings on the health benefits of fatty fish. However, further research into fatty acid derived mediators, and especially into the effects of Camelina sativa oil's metabolites, is needed.

Source:
Journal reference:

Meuronen, T., et al. (2020) Intake of Camelina Sativa Oil and Fatty Fish Alter the Plasma Lipid Mediator Profile in Subjects with Impaired Glucose Metabolism – A Randomized Controlled Trial. Prostaglandins, Leukotrienes & Essential Fatty Acids. doi.org/10.1016/j.plefa.2020.102143.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fish oil may benefit older adults with genetic Alzheimer's risk